NDC 17856-0273-2 - Codeine-Guaifenesin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0273
- Requested NDC
- 17856-0273-2
- Package NDCs from labels
- 17856-0273-2, 17856-0273-1
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2024-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Codeine-Guaifenesin - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-05-08 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0273-1 | 2024-05-08 | C162847 | 48780-1 | 1030e365-660e-111a-e063-dadaa90a10e2 | Codeine-Guaifenesin |
| 17856-0273-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-660e-111a-e063-dadaa90a10e2 | Codeine-Guaifenesin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0273-1 | Codeine-Guaifenesin | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0273-2 | Codeine-Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0273 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 2 package rows | 20240509_e9705358-3522-46b3-a860-afb9141968b4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0273-1 | ML - Milliliter | 17856-0273 | a0910118-47e5-4f96-9a75-8529d572bf0c | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Multi Symptom Cold and Multi Symptom Nighttime Cold Childrens | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI, ACETAMINOPHEN, DIPHENHYDRAMINE HCI, PHENYLEPHRINE HCI | TARGET Corporation | e3da3003-88e3-4431-8b65-e61e17728901 | 2024-06-04 | Warnings | M012 |
| Dimetapp Cold and Allergy | BROMPHENIRAMINE MALEATE | Foundation Consumer Healthcare | 15c3570c-bd00-8e43-e063-6294a90a8683 | 2024-06-01 | Warnings | M012 |
| Dimetapp Cold and Cough | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | Foundation Consumer Healthcare | 176be362-5237-edd8-e063-6294a90a4aef | 2024-06-01 | Warnings | M012 |
| Dimetapp Nighttime Cold and Cough | DIPHENHYDRAMINE HYDROCHLORIDE | Foundation Consumer Healthcare | 179115ad-d610-99b2-e063-6294a90ae711 | 2024-06-01 | Warnings | M012 |
| Dimetapp Cold and Cough and Nighttime Cold and Cough | DIPHENHYDRAMINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | Foundation Consumer Healthcare | 179259a9-231e-df03-e063-6294a90a145e | 2024-06-01 | Warnings | M012 |
| Dimetapp Cold and Cough and Dimetapp Nighttime Cold and Cough | BROMPHIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND DIPHENHYDRAMINE HYRDOCHLORIDE | Foundation Consumer Healthcare | 1820e7c7-bc11-9061-e063-6394a90ae581 | 2024-06-01 | Warnings | M012 |
| Theraflu Severe Cold Relief Combo Pack | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 682c5a4b-5ded-4276-903f-1ef1141ae518 | 2024-06-01 | Warnings | M012 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Maximum Strength Nasal Decongestant | OXYMETAZOLINE SPRAY | CVS Health | df1f8bda-7bf3-4755-9169-f2a81d824cbe | 2024-05-31 | Warnings | M012 |
| No Drip Nasal Mist | OXYMETAZOLINE SPRAY | CVS Health | a78d29ed-019b-4014-ae6f-c60c75d19c89 | 2024-05-31 | Warnings | M012 |
| Leader Nasal Decongestant | OXYMETAZOLINE HYDROCHLORIDE | Cardinal Health 110,Inc | 6594c117-6ffc-4bda-8bbf-e91c810f2c3f | 2024-05-31 | Warnings | M012 |
| MUCINEX | GUAIFENESIN | A-S Medication Solutions | 69c83a02-377f-4c6c-96f6-557b3a3d8ca1 | 2024-05-29 | Warnings | 495W7451VQ |
| Maximum Strength Mucus Relief | GUAIFENESIN | KROGER COMPANY | 100ff8e2-88ed-0e8c-e063-6294a90a5716 | 2024-05-25 | Warnings | 495W7451VQ |
| Nighttime Cold and Flu Relief Multi Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | United Natural Foods, Inc. dba UNFI | 1aba9b7c-8328-4a9f-8ce2-39648b2d8ae4 | 2024-05-23 | Warnings | M012 |
| Mucus Relief Severe Congestion and Cough Maximum Strength | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | fdf63308-fe7b-4613-a012-ed5e4c9f8ffe | 2024-05-23 | Warnings | M012 495W7451VQ |
| Mucus Relief Cold Flu and Sore Throat Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | e61ab02d-f932-403f-a4f7-0ca354607223 | 2024-05-23 | Warnings | M012 495W7451VQ |
| Daytime Cold and Flu Relief Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | United Natural Foods, Inc. dba UNFI | e4f9a846-ab72-4508-b0c5-f7911af2f3d7 | 2024-05-23 | Warnings | M012 |
| Mucus Relief | GUAIFENESIN | KROGER COMPANY | 100f59fb-f9e7-5acb-e063-6394a90af450 | 2024-05-21 | Warnings | 495W7451VQ |
| Adult Cough Relief | DEXTROMETHORPHAN HBR | QUALITY CHOICE (Chain Drug Marketing Association) | 6e35f30d-9b29-4468-9f5e-1ee2e9ac4b8c | 2024-05-20 | Warnings | M012 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.